Cytomedix, Inc. (AMEX: GTF)

Cytomedix, Inc. (AMEX: GTF), a biotechnology company, is focused on developing, selling and licensing regenerative biological therapies. Their AutoloGel(tm) System, a device used to produce platelet rich plasma gel derived from the patient’s own blood, has been cleared by the Food and Drug Administration (“FDA”) for use on a variety of exuding wounds. Currently, the Company is executing a multi-faceted strategy to infiltrate the chronic wound market with its AutoloGel(tm) System. For further information, visit the Company’s web site at www.cytomedix.com